BENJAMIN AARON: Open Payments
NPI 1811454077 · COOKEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 45 payments from 11 companies in 2025. Trend: 2023 $649 · 2024 $355 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $220 |
| Lilly USA, LLC | 9 | $115 |
| AstraZeneca Pharmaceuticals LP | 6 | $109 |
| Corcept Therapeutics | 3 | $67 |
| Phathom Pharmaceuticals, Inc. | 6 | $49 |
| PFIZER INC. | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $34 |
| Alkermes, Inc. | 1 | $26 |
| Amgen Inc. | 1 | $19 |
Products named: MOUNJARO, Ozempic, AIRSUPRA, Korlym, VOQUEZNA, XIFAXAN, ELIQUIS, CAPLYTA.
Industry payments across TN — which companies pay providers there.
